https://www.selleckchem.com/products/at13387.html
Objective To compare the actual health-system cost of elective labor induction at 39 weeks of gestation with expectant management. Methods This was an economic analysis of patients enrolled in the five Utah hospitals participating in a multicenter randomized trial of elective labor induction at 39 weeks of gestation compared with expectant management in low-risk nulliparous women. The entire trial enrolled more than 6,000 patients. For this subset, 1,201 had cost data available. The primary outcome was relative direct health care costs
Curtir
Comentario
Compartilhar
